The Unknown Side Effects of Petscan

The drug is not cheap and we don't yet know who's going to cover it, a cost that for the drug itself may be up to 56 thousand dollars a year. We also don't know how long re we goig to continue it for. When are we going to say that it's working or conclude that it's not working? How do you recommend that we balance some of these critical unknowns in our discussions with patients? These are vital unknown with regard to the treatment profile of people with this disease. If you engage in thetherapy, how are we goingto monitor whether, in fact, it's worked or not? I think we're going to have to follow people